Real-time enrollment status for this aml, adult clinical trial
Current Status
Recruiting
Checked: October 14, 2026 at 12:00 AM UTC
| NCT Number | NCT06533761 |
| Recruiting Status | Recruiting |
| Condition | AML, Adult |
| Phase | PHASE1 |
| Target Enrollment | 125 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Stelexis BioSciences |
| Last Updated on CT.gov | August 25, 2026 (Aug 25, 2026) |
As of October 14, 2026: Clinical trial NCT06533761 is currently recruiting participants. This phase1 study for aml, adult is actively seeking new participants at 11 locations across the United States. The study is sponsored by Stelexis BioSciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06533761 is actively recruiting participants as of October 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06533761 was last updated Aug 25, 2026 (August 25, 2026). HelloStudys verifies this status automatically.